Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
34
GDRX Quote, Financials, Valuation and Earnings
Last price:
$2.77
Seasonality move
:
-3.92%
Day range:
$2.69 - $2.76
52-week range:
$2.61 - $5.81
Dividend yield:
0%
P/E ratio:
32.01x
P/S ratio:
1.26x
P/B ratio:
1.55x
Volume:
2M
Avg. volume:
2M
1-year change:
-39.16%
Market cap:
$933.4M
Revenue:
$792.3M
EPS (TTM):
$0.09
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GDRX
GoodRx Holdings, Inc.
|
$194.5M | $0.09 | -2.9% | 420.34% | $4.88 |
|
CERT
Certara, Inc.
|
$104.6M | $0.11 | 3.04% | 150.07% | $12.54 |
|
DRIO
DarioHealth Corp.
|
$5.7M | -$2.42 | -32.08% | -68.96% | $18.25 |
|
FORA
Forian, Inc.
|
$7.3M | $0.01 | 32.51% | 56.25% | $2.10 |
|
NRC
National Research Corp.
|
-- | -- | -- | -- | -- |
|
SPOK
Spok Holdings, Inc.
|
$35.9M | $0.24 | 2.09% | 18.18% | $20.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GDRX
GoodRx Holdings, Inc.
|
$2.75 | $4.88 | $933.4M | 32.01x | $0.00 | 0% | 1.26x |
|
CERT
Certara, Inc.
|
$8.99 | $12.54 | $1.4B | 133.11x | $0.00 | 0% | 3.48x |
|
DRIO
DarioHealth Corp.
|
$10.14 | $18.25 | $24.3M | -- | $0.00 | 0% | 5.63x |
|
FORA
Forian, Inc.
|
$2.12 | $2.10 | $65.9M | 49.00x | $0.00 | 0% | 2.35x |
|
NRC
National Research Corp.
|
$19.01 | -- | $430.7M | 26.97x | $0.12 | 2.53% | 3.11x |
|
SPOK
Spok Holdings, Inc.
|
$12.93 | $20.00 | $266.3M | 16.16x | $0.31 | 9.67% | 1.92x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GDRX
GoodRx Holdings, Inc.
|
47.58% | 0.637 | 37.77% | 2.62x |
|
CERT
Certara, Inc.
|
22.36% | 0.910 | 15.74% | 1.94x |
|
DRIO
DarioHealth Corp.
|
29.69% | 1.040 | 75.99% | 3.72x |
|
FORA
Forian, Inc.
|
0.06% | 0.709 | 0.03% | 3.58x |
|
NRC
National Research Corp.
|
84.83% | 2.343 | 28.57% | 0.39x |
|
SPOK
Spok Holdings, Inc.
|
4.71% | 0.927 | 2.07% | 0.97x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GDRX
GoodRx Holdings, Inc.
|
$161.2M | $26.4M | 2.63% | 4.78% | 13.48% | $58M |
|
CERT
Certara, Inc.
|
$50.9M | $6.8M | 0.79% | 1.02% | 6.53% | $25.5M |
|
DRIO
DarioHealth Corp.
|
$3M | -$9.5M | -28.66% | -41.55% | -189.42% | -$7.4M |
|
FORA
Forian, Inc.
|
$4M | -$299.3K | -2.24% | -2.86% | -3.86% | -$439.7K |
|
NRC
National Research Corp.
|
$20M | $7.7M | 17.01% | 61.55% | 22.36% | $10.2M |
|
SPOK
Spok Holdings, Inc.
|
$20M | $4.5M | 10.33% | 10.88% | 13.38% | $7.6M |
GoodRx Holdings, Inc. vs. Competitors
-
Which has Higher Returns GDRX or CERT?
Certara, Inc. has a net margin of 0.57% compared to GoodRx Holdings, Inc.'s net margin of 1.46%. GoodRx Holdings, Inc.'s return on equity of 4.78% beat Certara, Inc.'s return on equity of 1.02%.
Company Gross Margin Earnings Per Share Invested Capital GDRXGoodRx Holdings, Inc.82.22% $0.00 $1.1B CERTCertara, Inc.48.67% $0.01 $1.4B -
What do Analysts Say About GDRX or CERT?
GoodRx Holdings, Inc. has a consensus price target of $4.88, signalling upside risk potential of 77.58%. On the other hand Certara, Inc. has an analysts' consensus of $12.54 which suggests that it could grow by 37.67%. Given that GoodRx Holdings, Inc. has higher upside potential than Certara, Inc., analysts believe GoodRx Holdings, Inc. is more attractive than Certara, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GDRXGoodRx Holdings, Inc.6 5 0 CERTCertara, Inc.6 7 0 -
Is GDRX or CERT More Risky?
GoodRx Holdings, Inc. has a beta of 1.470, which suggesting that the stock is 47.004% more volatile than S&P 500. In comparison Certara, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GDRX or CERT?
GoodRx Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Certara, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GoodRx Holdings, Inc. pays -- of its earnings as a dividend. Certara, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDRX or CERT?
GoodRx Holdings, Inc. quarterly revenues are $196M, which are larger than Certara, Inc. quarterly revenues of $104.6M. GoodRx Holdings, Inc.'s net income of $1.1M is lower than Certara, Inc.'s net income of $1.5M. Notably, GoodRx Holdings, Inc.'s price-to-earnings ratio is 32.01x while Certara, Inc.'s PE ratio is 133.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoodRx Holdings, Inc. is 1.26x versus 3.48x for Certara, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDRXGoodRx Holdings, Inc.1.26x 32.01x $196M $1.1M CERTCertara, Inc.3.48x 133.11x $104.6M $1.5M
-
Which has Higher Returns GDRX or DRIO?
DarioHealth Corp. has a net margin of 0.57% compared to GoodRx Holdings, Inc.'s net margin of -41.48%. GoodRx Holdings, Inc.'s return on equity of 4.78% beat DarioHealth Corp.'s return on equity of -41.55%.
Company Gross Margin Earnings Per Share Invested Capital GDRXGoodRx Holdings, Inc.82.22% $0.00 $1.1B DRIODarioHealth Corp.60.22% -$3.05 $106.6M -
What do Analysts Say About GDRX or DRIO?
GoodRx Holdings, Inc. has a consensus price target of $4.88, signalling upside risk potential of 77.58%. On the other hand DarioHealth Corp. has an analysts' consensus of $18.25 which suggests that it could grow by 79.98%. Given that DarioHealth Corp. has higher upside potential than GoodRx Holdings, Inc., analysts believe DarioHealth Corp. is more attractive than GoodRx Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GDRXGoodRx Holdings, Inc.6 5 0 DRIODarioHealth Corp.3 1 0 -
Is GDRX or DRIO More Risky?
GoodRx Holdings, Inc. has a beta of 1.470, which suggesting that the stock is 47.004% more volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.077, suggesting its more volatile than the S&P 500 by 7.716%.
-
Which is a Better Dividend Stock GDRX or DRIO?
GoodRx Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GoodRx Holdings, Inc. pays -- of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDRX or DRIO?
GoodRx Holdings, Inc. quarterly revenues are $196M, which are larger than DarioHealth Corp. quarterly revenues of $5M. GoodRx Holdings, Inc.'s net income of $1.1M is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, GoodRx Holdings, Inc.'s price-to-earnings ratio is 32.01x while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoodRx Holdings, Inc. is 1.26x versus 5.63x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDRXGoodRx Holdings, Inc.1.26x 32.01x $196M $1.1M DRIODarioHealth Corp.5.63x -- $5M -$2.1M
-
Which has Higher Returns GDRX or FORA?
Forian, Inc. has a net margin of 0.57% compared to GoodRx Holdings, Inc.'s net margin of -1.95%. GoodRx Holdings, Inc.'s return on equity of 4.78% beat Forian, Inc.'s return on equity of -2.86%.
Company Gross Margin Earnings Per Share Invested Capital GDRXGoodRx Holdings, Inc.82.22% $0.00 $1.1B FORAForian, Inc.50.97% -$0.00 $31.1M -
What do Analysts Say About GDRX or FORA?
GoodRx Holdings, Inc. has a consensus price target of $4.88, signalling upside risk potential of 77.58%. On the other hand Forian, Inc. has an analysts' consensus of $2.10 which suggests that it could fall by -0.94%. Given that GoodRx Holdings, Inc. has higher upside potential than Forian, Inc., analysts believe GoodRx Holdings, Inc. is more attractive than Forian, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GDRXGoodRx Holdings, Inc.6 5 0 FORAForian, Inc.0 1 0 -
Is GDRX or FORA More Risky?
GoodRx Holdings, Inc. has a beta of 1.470, which suggesting that the stock is 47.004% more volatile than S&P 500. In comparison Forian, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GDRX or FORA?
GoodRx Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Forian, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GoodRx Holdings, Inc. pays -- of its earnings as a dividend. Forian, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDRX or FORA?
GoodRx Holdings, Inc. quarterly revenues are $196M, which are larger than Forian, Inc. quarterly revenues of $7.8M. GoodRx Holdings, Inc.'s net income of $1.1M is higher than Forian, Inc.'s net income of -$151.2K. Notably, GoodRx Holdings, Inc.'s price-to-earnings ratio is 32.01x while Forian, Inc.'s PE ratio is 49.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoodRx Holdings, Inc. is 1.26x versus 2.35x for Forian, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDRXGoodRx Holdings, Inc.1.26x 32.01x $196M $1.1M FORAForian, Inc.2.35x 49.00x $7.8M -$151.2K
-
Which has Higher Returns GDRX or NRC?
National Research Corp. has a net margin of 0.57% compared to GoodRx Holdings, Inc.'s net margin of 11.54%. GoodRx Holdings, Inc.'s return on equity of 4.78% beat National Research Corp.'s return on equity of 61.55%.
Company Gross Margin Earnings Per Share Invested Capital GDRXGoodRx Holdings, Inc.82.22% $0.00 $1.1B NRCNational Research Corp.57.82% $0.18 $94.4M -
What do Analysts Say About GDRX or NRC?
GoodRx Holdings, Inc. has a consensus price target of $4.88, signalling upside risk potential of 77.58%. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that GoodRx Holdings, Inc. has higher upside potential than National Research Corp., analysts believe GoodRx Holdings, Inc. is more attractive than National Research Corp..
Company Buy Ratings Hold Ratings Sell Ratings GDRXGoodRx Holdings, Inc.6 5 0 NRCNational Research Corp.0 0 0 -
Is GDRX or NRC More Risky?
GoodRx Holdings, Inc. has a beta of 1.470, which suggesting that the stock is 47.004% more volatile than S&P 500. In comparison National Research Corp. has a beta of 0.447, suggesting its less volatile than the S&P 500 by 55.256%.
-
Which is a Better Dividend Stock GDRX or NRC?
GoodRx Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research Corp. offers a yield of 2.53% to investors and pays a quarterly dividend of $0.12 per share. GoodRx Holdings, Inc. pays -- of its earnings as a dividend. National Research Corp. pays out 45.99% of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios GDRX or NRC?
GoodRx Holdings, Inc. quarterly revenues are $196M, which are larger than National Research Corp. quarterly revenues of $34.6M. GoodRx Holdings, Inc.'s net income of $1.1M is lower than National Research Corp.'s net income of $4M. Notably, GoodRx Holdings, Inc.'s price-to-earnings ratio is 32.01x while National Research Corp.'s PE ratio is 26.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoodRx Holdings, Inc. is 1.26x versus 3.11x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDRXGoodRx Holdings, Inc.1.26x 32.01x $196M $1.1M NRCNational Research Corp.3.11x 26.97x $34.6M $4M
-
Which has Higher Returns GDRX or SPOK?
Spok Holdings, Inc. has a net margin of 0.57% compared to GoodRx Holdings, Inc.'s net margin of 9.46%. GoodRx Holdings, Inc.'s return on equity of 4.78% beat Spok Holdings, Inc.'s return on equity of 10.88%.
Company Gross Margin Earnings Per Share Invested Capital GDRXGoodRx Holdings, Inc.82.22% $0.00 $1.1B SPOKSpok Holdings, Inc.58.95% $0.15 $156.1M -
What do Analysts Say About GDRX or SPOK?
GoodRx Holdings, Inc. has a consensus price target of $4.88, signalling upside risk potential of 77.58%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 62.41%. Given that GoodRx Holdings, Inc. has higher upside potential than Spok Holdings, Inc., analysts believe GoodRx Holdings, Inc. is more attractive than Spok Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GDRXGoodRx Holdings, Inc.6 5 0 SPOKSpok Holdings, Inc.1 0 0 -
Is GDRX or SPOK More Risky?
GoodRx Holdings, Inc. has a beta of 1.470, which suggesting that the stock is 47.004% more volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.438, suggesting its less volatile than the S&P 500 by 56.19%.
-
Which is a Better Dividend Stock GDRX or SPOK?
GoodRx Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.67% to investors and pays a quarterly dividend of $0.31 per share. GoodRx Holdings, Inc. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.
-
Which has Better Financial Ratios GDRX or SPOK?
GoodRx Holdings, Inc. quarterly revenues are $196M, which are larger than Spok Holdings, Inc. quarterly revenues of $33.9M. GoodRx Holdings, Inc.'s net income of $1.1M is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, GoodRx Holdings, Inc.'s price-to-earnings ratio is 32.01x while Spok Holdings, Inc.'s PE ratio is 16.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoodRx Holdings, Inc. is 1.26x versus 1.92x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDRXGoodRx Holdings, Inc.1.26x 32.01x $196M $1.1M SPOKSpok Holdings, Inc.1.92x 16.16x $33.9M $3.2M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
